Advertisement

The Scientist

» clinical trials and microbiology

Most Recent

image: Week in Review: October 7–11

Week in Review: October 7–11

By | October 11, 2013

Nobels awarded for vesicle trafficking and computational chemistry; building 3-D microbial communities; mislabeled microbes cause retractions

0 Comments

image: Clinical Silence

Clinical Silence

By | October 10, 2013

A study has shown that less than half of the outcomes of some clinical trials are publicly available.

0 Comments

image: Progress for First Malaria Vaccine

Progress for First Malaria Vaccine

By | October 8, 2013

Following successful clinical trials, GlaxoSmithKline says it will submit its malaria vaccine for European regulatory approval.

0 Comments

image: Building 3-D Microbial Communities

Building 3-D Microbial Communities

By | October 7, 2013

Researchers apply a 3-D printing technique to structure populations of bacteria in a three-dimensional environment.

0 Comments

image: Trouble in the Heartland

Trouble in the Heartland

By | October 1, 2013

A new tick-borne disease has emerged in the US Midwest—and the culprit is not a bacterium. 

0 Comments

image: Week in Review: September 23–27

Week in Review: September 23–27

By | September 27, 2013

Antibiotic cycling makes a comeback in the lab; how life scientists can learn from astronauts; napping to conquer fears; deconstructing the cancer R&D crisis

0 Comments

image: Giving Antibiotic Cycling Another Shot

Giving Antibiotic Cycling Another Shot

By | September 25, 2013

Switching up the drugs used to treat bacterial infections could help clinicians battle both illness and resistance at the same time.

2 Comments

image: Criminal Hype

Criminal Hype

By | September 25, 2013

Overstating the benefits of a drug lands a former biotech executive in home detention.

0 Comments

image: Focus on the Host

Focus on the Host

By | September 18, 2013

A patient response-based gene expression signature can distinguish respiratory infections caused by viruses from those of bacterial or fungal origin.

1 Comment

image: Opinion: How HIV Became Positive

Opinion: How HIV Became Positive

By | September 17, 2013

Immunotherapies, such as the re-engineered T cells that last year saved a 7-year-old girl’s life, continue to show promise as cancer treatments.

1 Comment

Advertisement

Popular Now

  1. The Sum of Our Parts
    Features The Sum of Our Parts

    Putting the microbiome front and center in health care, in preventive strategies, and in health-risk assessments could stem the epidemic of noncommunicable diseases.

  2. Most Earth-like Planet Found
  3. Ancient Viruses as Gene Therapy Vectors
  4. Judge Decides on GM Rice Retraction
Advertisement
PDA
PDA
Advertisement